Mealey's (April 14, 2023, 1:15 PM EDT) -- YAKIMA, Wash. — Notwithstanding conflicting rulings by a Texas federal court and the Fifth Circuit U.S. Court of Appeals, a Washington federal judge on April 13 granted a motion by 17 states and the District of Columbia to clarify his April 7 order enjoining the Food and Drug Administration to maintain the status quo of the Risk Evaluation and Mitigation Strategy (REMS) for the abortion drug mifepristone, saying he has jurisdiction over the plaintiffs and that his injunction “must be followed” by the FDA “irrespective” of rulings to the contrary rulings by the Texas and Fifth Circuit courts....